Biotechnology Stocks I: Compare Returns of S&P 500 to Phathom Pharmaceuticals, Inc. (PHAT)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
Compare Returns for S&P 500 and PHAT | ||
---|---|---|
S&P 500 | PHAT | |
Start Date | Dec-01-2019 | Nov-29-2019 |
Start Price | $2,800.75 | $25.60 |
End Date | Apr-11-2025 | Apr-17-2025 |
End Price | $5,363.36 | $4.03 |
Number Monthly Prices | 66 | 66 |
Min Date | Mar-01-2020 | Apr-17-2025 |
Min Price | $3,240.69 | $4.03 |
Max Date | Dec-01-2024 | Feb-26-2021 |
Max Price | $6,010.09 | $44.05 |
Total Return | 37.57% | -84.26% |
Annualized Return | 5.97% | -28.55% |
Current Value of $1,000 Purchase | $1,376 | $157 |
Number Returns | 2,145 | 2,145 |
Average Return | 13.83% | -34.09% |
Minimum Return | -25.54% | -90.85% |
Maximum Return | 85.46% | 169.85% |
Number Profitable Returns | 1,660 | 456 |
Percent Profitable Returns | 77.39% | 21.26% |
Number Unprofitable Returns | 485 | 1,689 |
Percent Unprofitable Returns | 22.61% | 78.74% |
Profitable to Unprofitable Returns Ratio | 3.42 | 0.27 |
PHAT Performance Table and Chart
PHAT Dollar-cost Average
PHAT Trendline Chart
PHAT Moving Average Chart
PHAT Stock Return Map - See Patterns of Gains and Losses
PHAT Stock Returns/Purchase Dates